Want to join the conversation?
$AME 2Q15 PR: AMETEK posted 2Q15 results with net sales of $1003.7MM, up 1% vs. $990.7MM in 2Q14. Net income was $155.5MM vs. $150.06MM in 2Q14. Diluted EPS was $0.64, up 5% vs. $0.61 in 2Q14. Operating income rose 4% to a record $240.3MM and operating margins were up 50 bp to 23.9%. Dividends per share were $0.09, flat YoverY.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?